Olaris Global Panel (OGP): A Highly Accurate and Reproducible Triple Quadrupole Mass Spectrometry-Based Metabolomics Method for Clinical Biomarker Discovery
Open Access
- 11 May 2024
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 14 (5) , 280
Abstract
Mass spectrometry (MS)-based clinical metabolomics is very promising for the discovery of new biomarkers and diagnostics. However, poor data accuracy and reproducibility limit its true potential, especially when performing data analysis across multiple sample sets. While high-resolution mass spectrometry has gained considerable popularity for discovery metabolomics, triple quadrupole (QqQ) instruments offer several benefits for the measurement of known metabolites in clinical samples. These benefits include high sensitivity and a wide dynamic range. Here, we present the Olaris Global Panel (OGP), a HILIC LC-QqQ MS method for the comprehensive analysis of ~250 metabolites from all major metabolic pathways in clinical samples. For the development of this method, multiple HILIC columns and mobile phase conditions were compared, the robustness of the leading LC method assessed, and MS acquisition settings optimized for optimal data quality. Next, the effect of U-13C metabolite yeast extract spike-ins was assessed based on data accuracy and precision. The use of these U-13C-metabolites as internal standards improved the goodness of fit to a linear calibration curve from r2 < 0.75 for raw data to >0.90 for most metabolites across the entire clinical concentration range of urine samples. Median within-batch CVs for all metabolite ratios to internal standards were consistently lower than 7% and less than 10% across batches that were acquired over a six-month period. Finally, the robustness of the OGP method, and its ability to identify biomarkers, was confirmed using a large sample set.Keywords
Funding Information
- Olaris, Inc.
This publication has 42 references indexed in Scilit:
- Mass spectrometry-based metabolomics for clinical study: Recent progresses and applicationsTrAC Trends in Analytical Chemistry, 2022
- Metabolomics in degenerative brain diseasesBrain Research, 2021
- Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European PopulationJAMA Cardiology, 2019
- Overview of NMR Spectroscopy-Based Metabolomics: Opportunities and Challenges2019
- A systematic review on metabolomics-based diagnostic biomarker discovery and validation in pancreatic cancerMetabolomics, 2018
- 13 C-labelled yeast as internal standard for LC–MS/MS and LC high resolution MS based amino acid quantification in human plasmaJournal of Pharmaceutical and Biomedical Analysis, 2018
- COordination of Standards in MetabOlomicS (COSMOS): facilitating integrated metabolomics data accessMetabolomics, 2015
- Overview of Mass Spectrometry-Based Metabolomics: Opportunities and Challenges2014
- Challenges and developments in tandem mass spectrometry based clinical metabolomicsMolecular and Cellular Endocrinology, 2009
- Proposed minimum reporting standards for chemical analysisMetabolomics, 2007